Luther King Capital Management (LKCM)
EVH icon

Luther King Capital Management (LKCM)’s Evolent Health EVH Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-118,540
Closed -$644K – 515
2020
Q1 		$644K Buy
+118,540
New +$1.06M 0.01% 351

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Luther King Capital Management (LKCM)'s EVH Position: Q2 2020 in Review

Luther King Capital Management (LKCM) sold out of Evolent Health (EVH) in Q2 2020, closing a stake of 118,540 shares — an estimated $644K sold.

Luther King Capital Management (LKCM) first reported a position in EVH in Q1 2020 and held it in 1 quarter. The position peaked at $644K in Q1 2020. 136 funds tracked by Wall St. Rank hold EVH as of Q2 2020.

  • Luther King Capital Management (LKCM) reported no remaining Evolent Health position as of Q2 2020 after selling out during the quarter.
  • Luther King Capital Management (LKCM) sold 118,540 Evolent Health shares in Q2 2020, an estimated $644K.
  • Luther King Capital Management (LKCM) first reported a position in Evolent Health in Q1 2020 and held it in 1 quarter.
  • Luther King Capital Management (LKCM)'s Evolent Health position peaked at $644K in Q1 2020.
  • 136 funds tracked by Wall St. Rank held Evolent Health as of Q2 2020.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2020, filed 12 Aug 2020.